Oscillations in the basal ganglia under normal conditions and in movement disorders
P Gatev, O Darbin, T Wichmann - Movement disorders, 2006 - Wiley Online Library
A substantial body of work within the last decade has demonstrated that there is a variety of
oscillatory phenomena that occur in the basal ganglia and in associated regions of the …
oscillatory phenomena that occur in the basal ganglia and in associated regions of the …
The external globus pallidus: progress and perspectives
DJ Hegeman, ES Hong… - European Journal of …, 2016 - Wiley Online Library
The external globus pallidus (GP e) of the basal ganglia is in a unique and powerful position
to influence processing of motor information by virtue of its widespread projections to all …
to influence processing of motor information by virtue of its widespread projections to all …
Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry
Neural circuits of the basal ganglia are critical for motor planning and action selection,,. Two
parallel basal ganglia pathways have been described, and have been proposed to exert …
parallel basal ganglia pathways have been described, and have been proposed to exert …
'Rejuvenation'protects neurons in mouse models of Parkinson's disease
CS Chan, JN Guzman, E Ilijic, JN Mercer, C Rick… - Nature, 2007 - nature.com
Why dopamine-containing neurons of the brain's substantia nigra pars compacta die in
Parkinson's disease has been an enduring mystery. Our studies suggest that the unusual …
Parkinson's disease has been an enduring mystery. Our studies suggest that the unusual …
Prototypic and arkypallidal neurons in the dopamine-intact external globus pallidus
Studies in dopamine-depleted rats indicate that the external globus pallidus (GPe) contains
two main types of GABAergic projection cell; so-called “prototypic” and “arkypallidal” …
two main types of GABAergic projection cell; so-called “prototypic” and “arkypallidal” …
Parkinsonian beta oscillations in the external globus pallidus and their relationship with subthalamic nucleus activity
N Mallet, A Pogosyan, LF Márton, JP Bolam… - Journal of …, 2008 - Soc Neuroscience
Inappropriately synchronized beta (β) oscillations (15–30 Hz) in the subthalamic nucleus
(STN) accompany movement difficulties in idiopathic Parkinson's disease (PD). The cellular …
(STN) accompany movement difficulties in idiopathic Parkinson's disease (PD). The cellular …
[HTML][HTML] The globus pallidus orchestrates abnormal network dynamics in a model of Parkinsonism
The dynamical properties of cortico-basal ganglia (CBG) circuits are dramatically altered
following the loss of dopamine in Parkinson's disease (PD). The neural circuit dysfunctions …
following the loss of dopamine in Parkinson's disease (PD). The neural circuit dysfunctions …
A physiologically plausible model of action selection and oscillatory activity in the basal ganglia
MD Humphries, RD Stewart… - Journal of Neuroscience, 2006 - Soc Neuroscience
The basal ganglia (BG) have long been implicated in both motor function and dysfunction. It
has been proposed that the BG form a centralized action selection circuit, resolving conflict …
has been proposed that the BG form a centralized action selection circuit, resolving conflict …
[PDF][PDF] Increases in functional connectivity between prefrontal cortex and striatum during category learning
EG Antzoulatos, EK Miller - Neuron, 2014 - cell.com
Functional connectivity between the prefrontal cortex (PFC) and striatum (STR) is thought
critical for cognition and has been linked to conditions like autism and schizophrenia. We …
critical for cognition and has been linked to conditions like autism and schizophrenia. We …
Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's disease
MT Armentero, A Pinna, S Ferré, JL Lanciego… - Pharmacology & …, 2011 - Elsevier
Several selective antagonists for adenosine A2A receptors (A2AR) are currently under
evaluation in clinical trials (phases I to III) to treat Parkinson's disease, and they will probably …
evaluation in clinical trials (phases I to III) to treat Parkinson's disease, and they will probably …